Pressure BioSciences Q2 Revenues Plunge 53 Percent; Enough Capital to Last until Mid-September | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Pressure BioSciences on Monday reported revenues for the second quarter fell to $190,686, down 53 percent from a year ago as sales of its main platform and related consumables, as well as grant revenues, declined.

The South Easton, Mass.-based firm recorded total revenues of $402,104 during the second quarter of 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.